Gilbert Rishton is the founder of Cognition Therapeutics. Cognition Therapeutics has raised $36M in total funding. Latest round: Grant. Based in Purchase, NY.
Gilbert M. Rishton is a co-founder of Cognition Therapeutics, a clinical-stage biopharmaceutical company focusing on neuroscience and age-related degenerative disorders. He co-founded the company in 2007 and has been instrumental in the development of its lead drug candidate, CT1812, which has advanced into Phase II clinical studies for Alzheimer's disease.
Full founder directory · Investor directory · Company funding database · Fundraising library